| Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators | Circulation | 1999 | 735 |
| Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial | Circulation | 1999 | 433 |
| Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions | American Journal of Cardiology | 1999 | 204 |
| Potential molecular basis of different physiological properties of the transient outward K+ current in rabbit and human atrial myocytes | Circulation Research | 1999 | 172 |
| Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group | Circulation | 1999 | 125 |
| Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs | PACE - Pacing and Clinical Electrophysiology | 1999 | 112 |
| Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation | Cardiovascular Research | 1999 | 88 |
| The molecular and ionic specificity of antiarrhythmic drug actions | Journal of Cardiovascular Electrophysiology | 1999 | 77 |
| Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects | American Journal of Cardiology | 1999 | 57 |
| Modulation of Platelet-neutrophil Interaction with Pharmacological Inhibition of Fibrinogen Binding to Platelet GPIIb/IIIa Receptor | Thrombosis and Haemostasis | 1999 | 49 |
| Pilocarpine modulates the cellular electrical properties of mammalian hearts by activating a cardiac M3 receptor and a K+ current | British Journal of Pharmacology | 1999 | 48 |
| Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI) | Journal of the American College of Cardiology | 1999 | 46 |
| Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities : cause, consequence, or innocent bystander? | Circulation Research | 1999 | 42 |
| Outcome of children with atrial septal defect considered too small for surgical closure | American Journal of Cardiology | 1999 | 41 |
| Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts | Circulation | 1999 | 36 |
| Electrophysiologic remodeling: are ion channels static players or dynamic movers? | Journal of Cardiovascular Electrophysiology | 1999 | 33 |
| Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation | Cardiovascular Research | 1999 | 32 |
| Sauna-induced myocardial ischemia in patients with coronary artery disease | American Journal of Medicine | 1999 | 31 |
| Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI) | Journal of the American College of Cardiology | 1999 | 30 |
| Adrenergic control of the ultrarapid delayed rectifier current in canine atrial myocytes | Journal of Physiology | 1999 | 26 |
| Cytotoxicity and macrophage cytokine release induced by ceramic and polyethylene particles in vitro | Journal of Bone and Joint Surgery: British Volume | 1999 | 24 |
| Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) | Circulation | 1999 | 21 |
| Severe aortic regurgitation immediately after mitral valve annuloplasty | Annals of Thoracic Surgery | 1999 | 20 |
| Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans | American Journal of Physiology - Heart and Circulatory Physiology | 1999 | 18 |
| Optimal management with Class I and Class III antiarrhythmic drugs should be done in the outpatient setting: protagonist | Journal of Cardiovascular Electrophysiology | 1999 | 18 |
